跳至主要内容
临床试验/CTRI/2020/06/026262
CTRI/2020/06/026262已完成未知

Prospective , single center ,open label, randomized controlled , pilot study on evaluation of use of , â??AYURCOVâ?? as an adjuvant for treatment purpose in treatment of SARS-CoV-2 infection for covid-19 patients , at tertiary care center. - AYURCOV

Bhaktivedanta Hospital and Research Institute0 个研究点目标入组 120 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.COVID -19 Positive patients
  • 2.Agree to consent for the study.
  • 3.All Age groups above 18 Years
  • 4.All genders.

排除标准

  • 1. Unable to be followed-up during the trial
  • 2. Current or future involvement in the active treatment phase of other interventional research studies (excluding observational/non-interventional studies) .
  • 3. Any other clinical reason which may preclude entry in the opinion of the investigator.
  • 4, Pregnant Women.
  • 5.Patients who are on ventilator support .

研究者

发起方
Bhaktivedanta Hospital and Research Institute

相似试验

Single Center,Study on Evaluation of use... | 临床试验